Tag: Bexsero
-
Novartis Bexsero vaccine approved by the European Commission
On Tuesday, the pharmaceutical group Novartis announced that its Bexsero vaccine indicated for the prevention of meningitis B had just obtained the approval of the European Union. Advanced viewed as a major medical progress against this disease that can cause death and serious sequelae. Each year worldwide, more than one million people are affected by…
You must be logged in to post a comment.